Form D · Biotechnology

Voxcell BioInnovation Inc.

Victoria, A1 · CIK 0002041826

Offering snapshot reported Sep 1, 2026 · SEC filing

Reported sold
$2.2M
Offering amount: $2.2M
Investors reported
31
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 19, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 1, 2026Initial$2,200,676No comparison31SEC filing
Mar 24, 2025Initial$1,733,264No comparison10SEC filing
Nov 18, 2024Initial$1,536,603No comparison38SEC filing

Offering details

Securities
Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-596109
Amount of offering is CAD$3,058,213.50, and amount already sold is CAD$3,058,213.50. Amounts shown are based upon conversion to US Dollars at the time of this filing.
Simple Agreements for Future Equity (SAFEs) and the Equity or Security to be acquired upon conversion of the SAFEs

Source: Form D, filed Sep 1, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Qi Fang Director
Robert Levak Director
Jessica Miller Director
Mark Miller Director
Thomas Neumann Director
Marie Helene Raigneau Director
Karolina Papera Valente Director, Executive
Nina Vellani Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
300 637 Bay Street
Victoria, A1, V8T 5L2
Phone: 672-974-8850